Andrew Hindman
Director/Board Member en BIOTIE THERAPIES CORP .
Fortuna: 3 M $ al 31/03/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Deepa Pakianathan | M | 59 | 4 años | |
Antero Kallio | M | 64 | 19 años | |
Brett Grimaud | M | 50 | 3 años | |
Ronald Cohen | M | 68 | 8 años | |
Jane Wasman | F | 67 | 8 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Gregg Alton | M | 58 | 20 años | |
Brett Pletcher | M | 56 | 17 años | |
Mark Perry | M | 68 | 10 años | |
Robert Morales | M | 57 | 7 años | |
Linda Fitzpatrick | F | 67 | 10 años | |
Brett K. Haumann | M | 54 | 7 años | |
Adrian L. Rabinowicz | M | - | 6 años | |
Andrew Cheng | M | 57 | 19 años | |
Craig S. Gibbs | M | 61 |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | 3 años |
Catherine D. Strader | M | 70 | 4 años | |
Gail B. Cohen | F | - | 2 años | |
Susan Molineaux | M | 70 | 7 años | |
Robert Gunderson | M | 72 | 8 años | |
Bradford J. Shafer | M | 63 | 7 años | |
Ian Smith | M | 58 | 12 años | |
Helen Jenkins | F | 60 |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | - |
Nicholas G. Moore | M | 82 | - | |
Gayle Edlund Wilson | F | 81 | - | |
Carla A. Hills | F | 90 | - | |
Asif Ali | M | 50 | 4 años | |
Paul A. Berg | M | 97 | 13 años | |
Dana Pizzuti | M | 69 | 11 años | |
Peter S. Ringrose | M | 78 | 7 años | |
George M. Whitesides | M | 84 | 8 años | |
John Madigan | M | 86 | 12 años | |
John Francis Cogan | M | 76 | - | |
Jeff Enejosa | M | - |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | - |
Martine Kraus | M | - |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | - |
Andrew Aristidou | M | - | - | |
Shane Ward | M | 49 | 3 años | |
Jung Choi | F | 54 | 8 años | |
Robert Janssen | M | 70 | 2 años | |
Katie L. Watson | F | - | 16 años | |
Jeffrey Hessekiel | M | 55 | 10 años | |
Peter Virsik | M | - | 5 años | |
John Begley | M | - | - | |
Noreen Henig | M | 59 | 6 años | |
Stephen Cheng | M | - | 7 años | |
Elizabeth Bhatt | F | 56 | 11 años | |
Sung Lee | M | 53 | 14 años | |
Sharon Barbari | F | 70 | 4 años | |
Elizabeth Ann Fagan | M | 74 | 2 años | |
Monica Viziano | M | 57 | 18 años | |
Elvia Cowan | F | 51 | 3 años | |
Lian Hong Xu | M | 58 | 20 años | |
Christopher Kenney | M | - | 3 años | |
Lee Song | F | 49 | 14 años | |
Eric Lefebvre | M | 60 |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | - |
Erik Emerson | M | 53 | 3 años | |
Kitty Yale | F | 52 | 17 años | |
Carla Fiankan | F | - | 7 años | |
Peter Carbone | M | - | - | |
David Johnson | M | 55 | 15 años | |
Holly Kramen | F | - | 1 años | |
Brian P. Kearney | M | 52 | 21 años | |
Maria Fardis | M | 56 | 11 años | |
Caroline Dorsa | F | 64 | 1 años | |
Jennifer Burstein | F | 52 | 9 años | |
Caroline Loewy | F | 58 |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | 2 años |
Karl G. Trass | M | 64 | - | |
Richard Batycky | M | 56 | - | |
Mark D. Matteucci | M | 70 | 11 años | |
Kenneth Cundy | M | 65 | 8 años | |
Michael W. Aguiar | M | 57 | - | |
Alan Bruce Montgomery | M | 70 | 5 años | |
Kevin B. Young | M | 66 | 10 años | |
Antoun Nabhan | M | 49 |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | - |
J. William Freytag | M | 72 | 1 años | |
Robert L. Simon | M | 79 | 1 años | |
Nicole Onetto | M | 71 | 1 años | |
Gregory Critchfield | M | 72 |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | 6 años |
Jeff Bird | M | 63 | 12 años | |
Rebecca Coleman | M | - | 5 años | |
Kathleen A. McGowan | F | 63 |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | 4 años |
Kristen M. Metza | F | 64 | - | |
Melissa Yeager | F | - | 8 años | |
Enrique Carrazana | M | 62 | 5 años | |
Howard Rosen | M | 66 | 4 años | |
Phillip Gutry | M | 50 | 5 años | |
Stephan Reynier | M | 55 | 4 años | |
Brenda P. Fielding | F | - | 1 años | |
Mark Sullivan | M | - | 2 años | |
Christopher Griffith | M | 47 | 5 años | |
Soon H. Lee | M | - | - | |
Michael Hongjie Lan | M | 56 | - | |
Gabriel Fox | M | - | 4 años | |
Martin Freed | M | 63 | 1 años | |
Carol Brosgart | M | 72 | 11 años | |
Steven Pfeiffer | M | 48 | 4 años | |
James Sapirstein | M | 63 | 2 años | |
Kirk A. Christoffersen | M | 56 | 4 años | |
Steven Fife | M | 65 | 1 años | |
Paul Carter | M | 63 | 10 años | |
Benedict Osorio | M | 67 | 2 años | |
Aaron Brinkworth | M | - | 22 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 97 | 97.00% |
Finlandia | 3 | 3.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Andrew Hindman
- Red Personal